Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741971014 | Palivizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3741972019 | Product containing only palivizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4651811000052110 | läkemedel som endast innehåller palivizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Palivizumab only product in parenteral dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Palivizumab only product in parenteral dose form | Has active ingredient | Palivizumab (substance) | true | Inferred relationship | Some | 1 | |
| Palivizumab only product in parenteral dose form | Is a | Palivizumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Palivizumab only product in parenteral dose form | Is a | Palivizumab only product | true | Inferred relationship | Some | ||
| Palivizumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Palivizumab only product in parenteral dose form | Plays role | Antiviral therapeutic role | false | Inferred relationship | Some | ||
| Palivizumab only product in parenteral dose form | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Palivizumab only product in parenteral dose form | Inferred relationship | Some | |
| Palivizumab 50 mg powder for solution for injection vial | Is a | True | Palivizumab only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Palivizumab only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR